Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy

@inproceedings{Cenderello2013VariedSO,
  title={Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy},
  author={Giovanni Cenderello and Ambra Pasa and Andrea Dusi and Chiara Dentone and Federica Toscanini and Nicoletta Bobbio and Elisabetta Bondi and Valerio del Bono and Manuela Izzo and Giovanni Riccio and Marco Anselmo and Raffaella Giacchino and Maria Grazia Marazzi and Gabriella Pagano and Giovanni Cassola and Claudio Viscoli and Giuseppe Ferrea and Andrea de Maria},
  booktitle={BMC infectious diseases},
  year={2013}
}
BACKGROUND Visceral Leishmaniasis (VL) is endemic in 88 countries, in areas of relatively low incidence with a relevant proportion of immune suppressed patients clinical presentation, diagnosis and management may present difficulties and pitfalls. METHODS Demographic data, clinical, laboratory features and therapeutic findings were recorded in patients identified by a regional VL disease registry from January 2007 to December 2010. RESULTS A total of 55 patients (36 adults mean age 48.7… CONTINUE READING
BETA
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

Pediatric visceral leishmaniasis in southern France.

  • The Pediatric infectious disease journal
  • 1998
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Liposomal amphotericin B for the treatment of visceral leishmaniasis.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2006
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

on Global Surveillance of Epidemic-prone Infectious Diseases: Chapter ten Leishmaniasis and Leishmania HIV/coinfection: Background Information

WHO Repor
  • WHO; 2009. Available from: http://www.who.int/csr/resources/ publications/surveillance/Leishmaniasis.pdf last accessed May 03rd
  • 2012
VIEW 2 EXCERPTS

Decline of visceral leishmaniasis epidemic in HIV infected patients after the introduction of highly antiretroviral therapy

VR Lopez, JL Casado, V Pintado
  • Clin Microbiol Infect
  • 2011
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…